Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Applied Therapeutics, Inc. Director's Dealing 2024

Mar 18, 2024

34263_dirs_2024-03-18_7f475d28-0933-4d0e-a179-be64c836ce89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2023-12-28

Reporting Person: Chinoporos Constantine (See Remarks)

More from Applied Therapeutics, Inc.

Major Shareholding Notification 2026
Feb 17
Director's Dealing 2026
Feb 4
Director's Dealing 2026
Feb 3
Regulatory Filings 2026
Feb 3
Regulatory Filings 2026
Feb 3
Delisting Announcement 2026
Feb 3
Regulatory Filings 2026
Feb 3
Regulatory Filings 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
View all filings →